变应性鼻炎(allergic rhinitis,AR)是由免疫球蛋白(immunoglobulin E,IgE)介导的鼻黏膜非感染性慢性炎症,临床上比较常见,最近国内外大量的流行病学调查资料表明,发病率明显上升,已成为主要的呼吸道慢性炎性疾病之一~([1])。目前的主要治疗手段以糖皮质激素、抗组胺类及白三烯受体拮抗剂等药物治疗为主,而重组人干扰素γ(interferon-γ,INF-γ)在AR的治疗 Allergic rhinitis (AR) is a noninfectious chronic inflammation of the nasal mucosa mediated by immunoglobulin E (IgE). It is clinically common. A large number of epidemiological investigations at home and abroad show that the incidence of The rate has risen sharply and has become one of the major chronic inflammatory diseases of the respiratory tract ([1]). At present, the main treatment methods are glucocorticoid, anti-histamine and leukotriene receptor antagonist and other drug-based therapy, and recombinant interferon-γ (INF-γ) in the treatment of AR